Liquid Phase Peptide Synthesis Market Size

  • Report ID: 3221
  • Published Date: Jan 05, 2024
  • Report Format: PDF, PPT

Liquid Phase Peptide Synthesis Market Size

Liquid Phase Peptide Synthesis Market size is poised to reach USD  15 Billion by the end of 2036, growing at a CAGR of 10% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of liquid phase peptide synthesis was over USD 5 Billion. Growing Demand for peptide-based therapeutics due to their effectiveness in treating various diseases like cancer, metabolic disorders, and hormonal deficiencies fuels the LPPS market. Cancer is one of the leading causes of death globally, Current cancer treatment regimens often cause significant adverse side effects and fall short of effectively eliminating advanced disease. Because of the diverse functions that peptides offer, this nonviral carrier has rapidly gained exposure and popularity as a prospective delivery vehicle. In 2020, there were about 18.1 million cases of cancer worldwide.

Moreover, liquid-phase synthesis was the original method for creating peptides, numerous studies have looked into how to improve solid-phase synthesis in order to decrease costs, increase scalability, and waste less amino acids and solvents. High-volume industrial production uses liquid-phase peptide synthesis, which can produce higher-quality peptides at a cost of more time.


Liquid Phase Peptide Synthesis Market overview
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3221
  • Published Date: Jan 05, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing demand for peptide-based therapeutics, expanding applications, research and development, and supportive government policies are some of the major growth factors for the market’s growth.

The market size of liquid phase peptide synthesis is anticipated to attain a CAGR of 10 % over the forecast period, i.e., 2024-2036.

The major players in the market are CEM Corporation, Bachem AG, CSBio, Biotage, AnaSpec, ZenBio, Inc., Thermo Fisher Scientific Inc., GenScript, PolyPeptide Group, Sosei Group Corporation, Tokyo Mirai Style Co., Ltd., and others.

The Therapeutics segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample